Gava G - Search Results

1

Mancini I, Alvisi S, Gava G, Seracchioli R, Meriggiola MC. Mancini I, et al. Among authors: gava g. Int J Impot Res. 2020 Nov;33(7):710-719. doi: 10.1038/s41443-021-00412-z. Epub 2021 Feb 8. Int J Impot Res. 2020. PMID: 33558672 Review.

2

Long-term influence of combined oral contraceptive use on the clinical course of relapsing-remitting multiple sclerosis.

Gava G, Bartolomei I, Costantino A, Berra M, Venturoli S, Salvi F, Meriggiola MC. Gava G, et al. Fertil Steril. 2014 Jul;102(1):116-22. doi: 10.1016/j.fertnstert.2014.03.054. Epub 2014 Apr 29. Fertil Steril. 2014. PMID: 24794311 Free article.

3

Advances in male hormonal contraception.

Costantino A, Gava G, Berra M, Meriggiola Maria C. Costantino A, et al. Among authors: gava g. Indian J Med Res. 2014 Nov;140 Suppl(Suppl 1):S58-62. Indian J Med Res. 2014. PMID: 25673544 Free PMC article. Review.

4

Endocrine care of transpeople part I. A review of cross-sex hormonal treatments, outcomes and adverse effects in transmen.

Meriggiola MC, Gava G. Meriggiola MC, et al. Among authors: gava g. Clin Endocrinol (Oxf). 2015 Nov;83(5):597-606. doi: 10.1111/cen.12753. Epub 2015 Mar 25. Clin Endocrinol (Oxf). 2015. PMID: 25692791 Review.

5

Endocrine care of transpeople part II. A review of cross-sex hormonal treatments, outcomes and adverse effects in transwomen.

Meriggiola MC, Gava G. Meriggiola MC, et al. Among authors: gava g. Clin Endocrinol (Oxf). 2015 Nov;83(5):607-15. doi: 10.1111/cen.12754. Epub 2015 Mar 25. Clin Endocrinol (Oxf). 2015. PMID: 25692882 Review.

6

Hot issues in female and male hormonal contraception.

Gava G, Lantadilla C, Martelli V, Fattorini A, Seracchioli R, Meriggiola MC. Gava G, et al. Minerva Ginecol. 2016 Feb;68(1):78-89. Epub 2015 Dec 3. Minerva Ginecol. 2016. PMID: 26633041 Review.

7

Cyproterone acetate vs leuprolide acetate in combination with transdermal oestradiol in transwomen: a comparison of safety and effectiveness.

Gava G, Cerpolini S, Martelli V, Battista G, Seracchioli R, Meriggiola MC. Gava G, et al. Clin Endocrinol (Oxf). 2016 Aug;85(2):239-46. doi: 10.1111/cen.13050. Epub 2016 Mar 21. Clin Endocrinol (Oxf). 2016. PMID: 26932202

8

Effects of ospemifene on vaginal epithelium of post-menopausal women.

Alvisi S, Baldassarre M, Martelli V, Gava G, Seracchioli R, Meriggiola MC. Alvisi S, et al. Among authors: gava g. Gynecol Endocrinol. 2017 Dec;33(12):946-950. doi: 10.1080/09513590.2017.1332589. Epub 2017 May 31. Gynecol Endocrinol. 2017. PMID: 28562130

9

Laparoscopic Mesh-Less Cervicosacropexy for Uterovaginal Prolapse.

Seracchioli R, Raimondo D, Arena A, Gava G, Parmeggiani C, Martelli V, Moro E, Zanello M, Paradisi R, Mabrouk M. Seracchioli R, et al. Among authors: gava g. Female Pelvic Med Reconstr Surg. 2018 Nov/Dec;24(6):399-403. doi: 10.1097/SPV.0000000000000464. Female Pelvic Med Reconstr Surg. 2018. PMID: 28915136

10

Testosterone undecanoate and testosterone enanthate injections are both effective and safe in transmen over 5 years of administration.

Gava G, Mancini I, Cerpolini S, Baldassarre M, Seracchioli R, Meriggiola MC. Gava G, et al. Clin Endocrinol (Oxf). 2018 Dec;89(6):878-886. doi: 10.1111/cen.13821. Epub 2018 Aug 12. Clin Endocrinol (Oxf). 2018. PMID: 30025172

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

56 results

Search Page